Growing interest in stem cells for COVID-19 ailments, says Cynata
Stem cell therapies can treat COVID -19 complications says Cynata Therapeutics, which is in talks with potential development partners. The Australian biotech announced it was in talks in a March R&D update, telling investors industry interest in using mesenchymal stem cells (MSCs) to treat pa ...
Daiichi Sankyo has licensed a commercial-scale gene therapy manufacturing technology from Ultragenyx Pharmaceutical in a $200m deal.
The Japan ...
Takeda says COVID-19 therapy accord will work on TAK-888 and other plasma-derived meds developed by its partners.
The Japanese drug firm teame ...
Inovio Pharmaceuticals has asked VGXI to scale-up manufacturing of a potential DNA vaccine against COVID-19 after an initial production run provi ...
British American Tobacco (BAT) will use its tobacco-based expression technology to make a not-for-profit vaccine candidate targeting the novel co ...
Recent Tweets
-
RT @Dan5tanton: Still time to downloadfree @Xconomy and @EBDgroup special report on 'Containing #Coronavirus Through Innovation a… https://t.co/MIZ8uuLvDQ
19 hours ago
-
RT @Dan5tanton: Just released, @Xconomy and @EBDgroup special report on 'Containing #Coronavirus Through Innovation and Investment… https://t.co/t1giM4j2Eo
3 days ago
-
RT @Dan5tanton: It’s "absolutely business as usual” says @Cytiva , the bioprocess vendor formerly known as #GEHealthcare Life Scien… https://t.co/WyRu3ccbn3
1 week ago
-
RT @Xconomy: Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus
- by @Dan5tanton
https://t.co/0RMf0hP3nL $JNJ
1 week ago
Trending
Upstream Processing
eBook: Microbial Fermentation — The Right Choice for Large Peptides and Small Proteins
Ask the Experts
Cryogenic Temperatures and Cell Viability
Ask the Experts
Mixed-Mode Chromatography Resins for Biomolecule Purification
BPI White Papers
Understanding and Controlling Raw Materials Variation in Cell Culture Media